QTMeds

Drug Database Monograph

CANDAZOL 300 mg

PENDING REVIEW

Active Ingredient: SERTACONAZOLE

QTc Interval Status:

neutral

Clinical Description (Database Summary)

Scientific Sources / References

Analyse RCP (Automatique), id : 63090616

← Back to Prescription Analyzer